5Foell J, Hewes B, Mittler RS. T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity [J]. Curr Cancer Drug Targets, 2007; 7(1)∶55
6Scharpf J, Strome M, Siemionow M. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts [J]. Microsurgery, 2006; 26(8)∶599
7Lee JH, Ha J, Kim SH, et al. IL-2 pathway blocking in combination with anti-CD154 synergistically establishes mixed macrochimerism with limited dose of bone marrow cells and prolongs skin graft survival in mice [J]. J Korean Med Sci, 2006; 21(6)∶1005
8Chavez H, Beaudreuil S, Abbed K, et al. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade [J]. Transpl Immunol, 2007; 17(4)∶243
9Li ZL, Xue WJ, Tian PX, et al. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice [J]. Transplant Proc, 2007; 39(10)∶3436
10Yamazaki M, Pearson T, Brehm MA, et al. Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice [J]. Am J Transplant, 2007; 7(7)∶1710